Voichita Bar-Ad1, Mark Mishra, Nitin Ohri, Charles Intenzo. 1. Department of Radiation Oncology, Thomas Jefferson University, 111 S. 11th Street, Philadelphia, PA 19107, USA. Voichita.Bar-Ad@Jeffersonhospital.org
Abstract
OBJECTIVES: The objective of the current review was to assess published data on the role of Positron Emission Tomography (PET) for evaluation of nodal residual disease after definitive chemoradiotherapy for head and neck squamous cell carcinoma (HNSCC). METHODS: Studies were identified by searching PubMed electronic databases. Only studies using a post-chemoradiotherapy PET for nodal residual disease evaluation were included in the present review. Both prospective and retrospective studies were included. Information regarding sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of PET for detecting nodal residual disease after definitive chemoradiotherapy for HNSCC was extracted and analyzed. RESULTS: Twenty published studies were included in the present review. Existing data suggest that a negative post-chemoradiotherapy PET scan is associated with a negative predictive value up to 100%. The sensitivity of PET in detecting nodal residual disease is greater for scans performed ≥ 10 weeks after definitive treatment with chemoradiotherapy for HNSCC. CONCLUSIONS: Further studies are needed to quantify the reliability of PET in detecting nodal residual disease after chemoradiotherapy for locoregionally advanced HNSCC. The optimal timing of PET imaging after chemoradiotherapy remains to be defined.
OBJECTIVES: The objective of the current review was to assess published data on the role of Positron Emission Tomography (PET) for evaluation of nodal residual disease after definitive chemoradiotherapy for head and neck squamous cell carcinoma (HNSCC). METHODS: Studies were identified by searching PubMed electronic databases. Only studies using a post-chemoradiotherapy PET for nodal residual disease evaluation were included in the present review. Both prospective and retrospective studies were included. Information regarding sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of PET for detecting nodal residual disease after definitive chemoradiotherapy for HNSCC was extracted and analyzed. RESULTS: Twenty published studies were included in the present review. Existing data suggest that a negative post-chemoradiotherapy PET scan is associated with a negative predictive value up to 100%. The sensitivity of PET in detecting nodal residual disease is greater for scans performed ≥ 10 weeks after definitive treatment with chemoradiotherapy for HNSCC. CONCLUSIONS: Further studies are needed to quantify the reliability of PET in detecting nodal residual disease after chemoradiotherapy for locoregionally advanced HNSCC. The optimal timing of PET imaging after chemoradiotherapy remains to be defined.
Authors: Amy G Rabalais; Rohan Walvekar; Daniel Nuss; Andrew McWhorter; Charles Wood; Robert Fields; Donald E Mercante; Anna M Pou Journal: Laryngoscope Date: 2009-06 Impact factor: 3.325
Authors: June Corry; Lester Peters; Richard Fisher; Andrew Macann; Michael Jackson; Bev McClure; Danny Rischin Journal: Head Neck Date: 2008-06 Impact factor: 3.147
Authors: Seng Chuan Ong; Heiko Schöder; Nancy Y Lee; Snehal G Patel; Diane Carlson; Matthew Fury; David G Pfister; Jatin P Shah; Steven M Larson; Dennis H Kraus Journal: J Nucl Med Date: 2008-03-14 Impact factor: 10.057
Authors: Alfio Ferlito; June Corry; Carl E Silver; Ashok R Shaha; K Thomas Robbins; Alessandra Rinaldo Journal: Head Neck Date: 2010-02 Impact factor: 3.147
Authors: Jayakar V Nayak; Rohan R Walvekar; Regiane S Andrade; Nicole Daamen; Stephen Y Lai; Athanassios Argiris; Ryan P Smith; Dwight E Heron; Robert L Ferris; Jonas T Johnson; Barton F Branstetter Journal: Laryngoscope Date: 2007-12 Impact factor: 3.325
Authors: Min Yao; Russell B Smith; Henry T Hoffman; Gerry F Funk; Minggen Lu; Yusuf Menda; Michael M Graham; John M Buatti Journal: Int J Radiat Oncol Biol Phys Date: 2008-10-17 Impact factor: 7.038
Authors: Christine G Gourin; Brian J Boyce; Hadyn T Williams; Anne V Herdman; Paul A Bilodeau; Teresa A Coleman Journal: Laryngoscope Date: 2009-11 Impact factor: 3.325
Authors: Benjamin J Moeller; Vishal Rana; Blake A Cannon; Michelle D Williams; Erich M Sturgis; Lawrence E Ginsberg; Homer A Macapinlac; J Jack Lee; K Kian Ang; K S Clifford Chao; Gregory M Chronowski; Steven J Frank; William H Morrison; David I Rosenthal; Randal S Weber; Adam S Garden; Scott M Lippman; David L Schwartz Journal: J Clin Oncol Date: 2009-03-30 Impact factor: 44.544